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America….We Have A Problem…

Not Just Adults…Children and Teens 
Too
We’ve Been “Super-Sized”
On Average, Servings and Meals Are 
Bigger
A tasty 750 
calories
And so are 
we………
Our Grocery-buying Habits Have 
Changed
Adults and Children Spend Most of 
Their Time Sitting
And Too Little of Our Time in Physical 
Activity
So…What Does Our “Weight Problem” 
Have to Do With Health??
Overweight and Obesity are “Warning 
Signs
Our “Weight Problem” and Type 2 DM

Remember When T2DM Was “Adult 
Onset” Diabetes???
A Word About “BMI” As A Designator 
of Overweight and Obesity
• It is based simply on height and weight
• BMI= wt.(lbs) x 703 ÷ ht. (in. squared)
• Does not take into account lean body mass
• Waist : hip ratio might be a better classifier
• However…it is quick, based on simple to obtain 
measures
• There is no doubt that a BMI ≥ 35 indicates obesity, 
and a BMI  ≥ 40 indicates “morbid” obesity
• 25.6% of those with BMI’s ≥ 40 have type 2 diabetes
Development of Type 2 Diabetes
• Many of us consume foods high in sugars and 
starches
• Bombarded by high amounts of glucose, beta 
cells of pancreas secrete more insulin
• So much  that, in time, cells’ insulin receptors 
become resistant, so that cells are unable to 
take up glucose effectively
• Blood glucose level remains chronically high



Insulin Production Also Mediated by 
Hormones Known as Incretins
Intestine – mediated Secretion of Insulin
Glucagon-Like Peptide 1 & Glucose-
dependent Insulinotropic Polypeptide
• Both are secreted by cells in the intestine, in 
response to food entering the intestine
• Enhance insulin release in response to food intake –
particularly carbohydrates
• In non-diabetics, account for up to 50% of insulin 
released
• Have a protective effect on beta cells, reduction in 
rate of apoptosis and enhancing neogenesis
• Incretin effects are blunted in type 2 diabetes

Progressive Deterioration of ẞ-Cell 
Function
• By the time of diagnosis, the process of beta 
cell “fatigue” and acceleration of apoptosis 
may have been ongoing for as much as 10-12 
years
• Beta cell mass may be decreased as much as 
50%
• Effects of hyperglycemia may have brought 
about damage to kidneys, nerves, and blood 
vessels
At Time of Diagnosis, Typical T2 
Diabetic Has:
• BMI ≥ 35, usually with truncal obesity
• HgbA1c ≥ 10
• Elevated blood pressure
• Elevated blood lipids
• Possibly some symptoms of peripheral 
neuropathy (tingling, numbness-hands/feet)
• Possibly some blurring of vision
Progression of Therapies
• Lifestyle modification: diet, exercise, stop smoking + 
oral medications + education and everything we can 
think of to encourage compliance
• Among compliant patients, some achieve good 
control (HgbA1c ≤ 6.5)
• Alas, compliance is not a common trait, and many 
progress to a regimen of long-and-short acting 
insulins
• Treatment is costly; an oral med + two insulins, over 
10 years = $86,800.
Some Encouraging New Agents
• Agents that inhibit DPP-4 enzyme – that’s the one 
that inactivates incretins
– Sitagliptin (Januvia). Saxagliptin (Onglyza) and 
Linagliptin (Tradjenta) 
– They can work well, but tend to be “top tier” on 
the insurance coverage ladder; can cost $200 or 
more/month
• GLP1 agonists : extenatide (Byetta) and Liraglutide
(Victoza) –short and long-acting synthetic extendin
• These are also quite expensive, and often either not 
covered, or are “top tier”, with high co-pay
Extendin – Extracted From Saliva of 
the Gila Monster
For the Majority of Type 2 Diabetics:
• Once insulin is added, obesity is increased
• Added weight increases back and joint stress
• Control of glucose level waxes and wanes; 
even among compliant patients, the “24-7” 
average blood glucose is 150-160
• Slow, inexorable damage is done to kidneys, 
nerves, blood vessels, and heart
• It’s a “No Win” situation
So…What About Bariatric Surgery?
• Your patients usually have BMI’s ≥ 40; i.e. they 
are “morbidly obese”
• It’s “come a long way” since the early days of 
open surgical gastric bypass
• Laparoscopic procedures now the “state of the 
art”; patients usually discharged on 2nd or 3rd
post-op day
• …And blood glucose levels fall long before 
curtailed calorie intake and weight loss could 
bring about decreases
It’s Time to Consider It
• STAMPEDE study (2012): 6-yr. follow-up – 50% achieved 
complete or partial remission, 24% with no medication, and 
26% needing only an oral agent, typically metformin, to hold 
HgbA1c ≤ 6.0.  Signs of diabetic nephropathy improved or 
stabilized as well
• A Utah study followed 418 obese diabetics post gastric by-
pass surgery.  At 6 yrs. Post-op, 62% had total or partial 
remission of diabetes, and significant improvement in blood 
lipid profiles, and hypertension. 
• Swedish study followed 600 diabetics for 20 yrs. Post- GBP; 
72% remission at 2 yrs., dropping to 36% at 10 yrs., and 18% 
at 20 yrs. All had fewer co-morbidities at 20 yrs than diabetics 
who had not had bariatric surgery
But….Findings Beyond Diabetes 
Remission…..
• At 20 years, the GBP group had a much lower 
incidence of complications involving kidneys, 
eyes, circulation, and peripheral nerves 
compared to the control group of diabetics 
who did not have gastric by-pass (20% / 45%)
• It’s those complications that account for the 
vast majority of diabetics requiring dialysis, 
amputations, and coronary stents or grafts

Bariatric Procedures
• Restrictive: 
– Limited intake capacity; normal flow of food 
preserved
• Restrictive + Reduced Absorption of Nutrients
– Limited intake capacity; absorption length of small 
intestine moderately shortened; gut hormone 
effect on pancreas and liver enhanced; digestive 
hormones from stomach and duodenum 
preserved 
Restrictive Bariatric Procedures
Adjustable Band Gastroplasty
Roux-en-Y: Combination of Restrictive 
and Altered Pathway
• Choice for 80% of
patients in most
centers; pouch about
30 ml. capacity; most
of absorptive length
preserved; stomach,
duodenum and short
segment of jejunum by-
passed; upper limb re-
connected, restoring 
continuity
Complication Rates for Laparoscopic 
Bariatric Surgeries
• Mortality: 
– AGB : 0.05%;  RYGBP:  0.5%
• Bleeding
– AGB: 0.1%;  RYGBP:  0.4-4.0%
• Deep vein thrombosus
– AGB: 0.-1%;  RYGBP:  0% - 1.3%
• Pulmonary embolus
– AGB: 0.1%;  RYGBP:  0% - 1.1%
T2 Diabetes Remission: RYGBP and 
AGB Procedures


Results: Wt. Loss and Blood Glucose 
Control
• Patients receiving any type of bariatric surgery 
lose weight; RYGBP ≥ AGB
• Remission of type 2 diabetes
– RYGBP: 80.3%;  AGB:  56.7%
– Total remission persists for varying lengths of 
time; 2 – 10 years reported in most studies. In 
patients who need medication to maintain 
glycemic control, typically one oral drug, or a GLP-
1 agonist like victoza is sufficient 
Why Does This Happen, and Why Does 
Roux-en-Y Seem More Effective?
• Decreased caloric intake
• Somewhat lessened intestinal absorption of 
nutrients
• Food enters incretin-producing portion of 
intestine sooner, stimulating release of the 
incretins and peptide YY
• Those stimulate release of insulin, and 
produce feeling of satiety.
Who Is A Candidate?
• BMI ≥ 40; type 2 diabetes, or BMI ≥ 35 plus a 
comorbidity (hyperlipidemia; sleep apnea; 
arthritis)
• Patient who have demonstrated compliance with 
glucose monitoring, medication regimens
• Patients who demonstrate understanding of post-
surgery eating patterns, and need for life-long 
vitamin supplements (A, D, E, K, C, Iron, Zinc, and 
B₁₂) and will commit to long-term follow-up
What’s the Cost?
• It depends on where you are located; large cities typically 
have practices specializing in bariatric surgeries
• In New York, cost average is $21,000, which includes surgery 
and follow-up, anesthesia, and hospital stay.  In Houston, $21-
22,000.
• A clinic in Michigan offers an all-inclusive “package” for 
$19,500
• Medicare and most insurances do provide coverage
• There likely will be visits to nutritionist periodically; patients 
will require life-long supplements: A,D,E,K,C,B₁₂, iron, zinc
• Not to mention…new clothes, or lots of alterations!
Sounds Expensive…But Consider…
• An obese type 2 diabetic, age 40, who does 
not have the surgery will spend $373,600 on 
the typical regimen of diabetes medications 
over the next 20 years
• Add to that the cost of anti-hypertensive and 
anti-hyperlipidemic drugs they will likely need, 
and the cost of surgery doesn’t look like a big 
obstacle
Intangible “Quality of Life” Benefits
Self-esteem; ability to work, and perhaps be considered 
more “employable”
Able to enjoy physical activity and its benefits
Enjoy a better “energy level”
Having to take fewer medicines
Overall, just “feel better”
After All This…My Answer Is YES!
• I was a “nay-sayer” as regards bariatric surgery for 
diabetics…or anyone!
• But after seeing some dramatic changes in our 
patients who’ve chosen to have it…and reviewing 
research…I’ve changed my mind!
• We should present it as an option
• Yes, they will have to be willing
to be compliant, and may still
require some medicine…and still
need to monitor BG, but all-in-all, it seems to offer
significant advantages! 
